Bristol-Myers Squibb Company PFD CONV 2 PEG Ratio

Bristol-Myers Squibb Company PFD CONV 2 posts a PEG ratio of 3388.4. That is above the Healthcare sector average of 12.15. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

For Healthcare stocks, a PEG ratio near 12.15 is typical. Bristol-Myers Squibb Company PFD CONV 2's 3388.4 is higher that level. That is roughly 27781.4% above the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Bristol-Myers Squibb Company PFD CONV 2's PEG ratio of 3388.4 comes from dividing a price-based measure by a related financial statistic. Changes can come from the stock price moving, the underlying fundamental shifting, or both. Track both the level and the trend — a rising multiple on falling fundamentals is a different story than a rising multiple on rising earnings.

Context for BMYMP's PEG ratio usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 12.15), and (3) consistency with growth and profitability. This page covers the first two; Bristol-Myers Squibb Company PFD CONV 2's other metric pages and overview cover the third.

Judging Bristol-Myers Squibb Company PFD CONV 2 against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in PEG ratio easier to interpret. Start with 3388.4 here, then scan peer and history charts to see if the gap is persistent.